anti cox2 (ABclonal Biotechnology)
Structured Review
Anti Cox2, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 5 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cox2/MTCO2+Rabbit+mAb/pm42849804-72-42-44
Average 93 stars, based on 5 article reviews
Images
Related Articles
other:Article Title: Aniline exposure induces intestinal inflammation and IBD-like pathological changes via ATF2-mediated apoptosis in mouse intestinal epithelial cells. Article Snippet: The primary antibodies included Claudin 1 Rabbit mAb (#A11530, ABclonal Technology, Wuhan, China), ZO-1 Rabbit pAb (#A0659, ABclonal Technology, Wuhan, China), Occludin Rabbit mAb (#A25320, ABclonal Technology, Wuhan, China), p38 MAPK Rabbit mAb (#A5049, ABclonal Technology, Wuhan, China), Phospho-p38 MAPK-T180 Rabbit mAb (#AP1508, ABclonal Technology, Wuhan, China), Bax Rabbit pAb (#A12009, ABclonal Technology, Wuhan, China), Cleaved Caspase-3 (Asp175) Antibody (#9661, Cell Signaling Technology, Massachusetts, USA), Bcl-2 Rabbit mAb (#A19693, ABclonal Technology, Wuhan, China), TNF-α Rabbit pAb (#A11534, ABclonal Technology, Wuhan, China), IL17A Rabbit pAb (#A12454, ABclonal Technology, Wuhan, China), CD68 Rabbit mAb (#A13286, ABclonal Technology, Wuhan, China), ATF2 Rabbit mAb (#A22718, ABclonal Technology, Wuhan, China), MTCO2 Rabbit mAb (#A3843, ABclonal Technology, Wuhan, China), Phospho-ATF2-T69/T71 Rabbit pAb (#AP0525, ABclonal Technology, Wuhan, China), JNK1/2/3 Rabbit mAb (#A4867, ABclonal Technology, Wuhan, China), Article Title: lncRNA ZNF593-AS inhibits cardiac hypertrophy and myocardial remodeling by upregulating Mfn2 expression. Article Snippet: lncRNA ZNF593 antisense (ZNF593-AS) transcripts have been implicated in heart failure through the regulation of myocardial contractility.. The decreased transcriptional activity of ZNF593-AS has also been detected in cardiac hypertrophy.. However, the function of ZNF593-AS in cardiac hypertrophy remains unclear. Article Title: Targeting the PHF8/YY1 axis suppresses cancer cell growth through modulation of ROS Article Snippet: Antibodies Antibodies used in this study are listed as following: Rabbit polyclonal anti-PHF8 (Abcam, ab36068); Rabbit polyclonal anti-YY1 (C-20) (Santa Cruz Biotechnology, sc281); Rabbit polyclonal anti-YY1 (H-414) (Santa Cruz Biotechnology, sc-1703); Rabbit polyclonal anti-YY1 (H-10) (Santa Cruz Biotechnology, sc-7341); Rabbit polyclonal anti-GFP (Proteintech, 50430-2-AP); Mouse monoclonal anti-Flag M2 (Sigma, F3165); Rat monoclonal anti-HA (clone 3F10) (Roche, 11867431001); Mouse monoclonal antiActin (C-2) (Santa Cruz Biotechnology, sc-8432); Rabbit polyclonal antiYY1K258me1/2/3 (ABclonal); Western Blot:Article Title: Phase separation of Nur77 mediates celastrol-induced mitophagy by promoting the liquidity of p62/SQSTM1 condensates. Article Snippet: .. For Western blot, the following antibodies were used: Myc (9E10) (Santa Cruz, sc-40, dilution: 1:1000), FLAG (Sigma-Aldrich, F1804, dilution: 1:1000), GFP (Santa Cruz, sc-9996, dilution: 1:1000), Article Title: SLC6A6 deficiency inhibits angiogenesis by impairing mitochondrial respiration and inducing ferroptosis. Article Snippet: Targeting endothelial angiogenesis holds significant promise in the treatment of hypoxic/ischemic diseases and tumors.. Previous studies have shown that solute carrier family 6 member 6 (SLC6A6) plays critical roles in promoting cancer cell survival and proliferation.. However, the role of SLC6A6 in regulating endothelial angiogenesis remains unexplored. |

